BioXcel Therapeutics Inc
Change company Symbol lookup
Select an option...
BTAI BioXcel Therapeutics Inc
GDX VanEck Vectors Gold Miners ETF
CTVA Corteva Inc
WDC Western Digital Corp
VER VEREIT Inc
STOR STORE Capital Corp
BKCC BlackRock Capital Investment Corp
MANH Manhattan Associates Inc
RF Regions Financial Corp
QRVO Qorvo Inc
Go

Health Care : Biotechnology |
Company profile

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company that is focused on the development of drugs for psychiatric disorders and rare cancers. The Company uses novel artificial intelligence (AI) for drug re-innovation processes of approved product candidates to identify new therapeutic indices. Its principal clinical development programs are BXCL501 and BXCL701. BXCL501 is a sublingual thin film formulation of dexmedetomidine (Dex) designed for the acute treatment of agitation resulting from neurological and psychiatric disorders. BXCL701 is an immuno-oncology agent designed for the treatment of prostate and pancreatic cancer.

Closing Price
$46.56
Day's Change
3.56 (8.28%)
Bid
--
Ask
--
B/A Size
--
Day's High
47.39
Day's Low
41.27
Volume
(Heavy Day)
Volume:
699,436

10-day average volume:
426,832
699,436
  • Prev Close
    43.00
  • Today's Open
    43.33
  • Day's Range
    41.27-47.39
  • Avg Vol (10-day)
    426.8K
  • Last (time)
    3:59p ET 05/29/20
  • Last (size)
    5
  • 52-Wk Range
    3.76 - 51.83
    LowHigh
  • (11/01/19 - 05/19/20)
    10.17%
  • 126.4%
  • Market Cap
    941.0M
  • Shares Outstanding
    20.2M
  • -2.36
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 32.72
  • (% of float 05/15/20)
    7.45

Latest News

May 28, 2020
7:00 am ET
Globe Newswire
May 14, 2020
7:00 am ET
Globe Newswire
May 12, 2020
8:51 am ET
Globe Newswire
May 11, 2020
7:00 am ET
Globe Newswire
May 07, 2020
7:01 am ET
Globe Newswire
May 05, 2020
7:00 am ET
Globe Newswire
April 30, 2020
10:45 am ET
PR Newswire
April 28, 2020
7:00 am ET
Globe Newswire
March 24, 2020
4:23 pm ET
MarketWatch
March 19, 2020
7:15 am ET
Globe Newswire
March 10, 2020
9:11 am ET
MarketWatch
March 09, 2020
7:00 am ET
Globe Newswire
6:00 am ET
Accesswire
March 06, 2020
8:30 am ET
PR Newswire
March 02, 2020
7:00 am ET
Globe Newswire
February 21, 2020
8:52 am ET
MarketWatch
January 16, 2020
9:18 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.